HIV Prevention Methods

CROI (Conference on Retroviruses and Opportunistic Infections)

The Latest

Sundararajan Team and TBA

Traditional Healers Offer a Culturally Competent Approach to HIV Testing Gaps

In sub-Saharan Africa, herbalists and spiritual healers are working closely with researchers to help reduce HIV transmission in rural communities.

By Terri Wilder, M.S.W.
photo of David Alain Wohl, M.D., as he recaps research from CROI 2021

As CROI 2021 Attests, the PrEP Revolution Is Coming

Analysis from David Alain Wohl, M.D., on new research in on HIV prevention, especially in areas that will expand and transform PrEP options.

By David Alain Wohl, M.D.

Long-Acting ART Is Here. How Do We Make It Work for Our Patients?

Injectable HIV interventions are a game-changing new option for people dealing with pill fatigue, but there are implementation challenges for clinicians to consider.

By Larry Buhl
photo of David Alain Wohl, M.D., as he recaps research from CROI 2021

Broadly Neutralizing Antibodies for HIV? If We Can Do It for COVID ...

David Alain Wohl, M.D., shares his thoughts on broadly neutralizing antibodies for COVID-19—and the extent to which we can hope to see similar developments in HIV.

By David Alain Wohl, M.D.
injection vials

Long-Acting HIV Treatment and PrEP Pipeline Update: So Many Formulations!

CROI 2021 featured new research on a host of long-acting antiretrovirals in development, including less-frequent treatment injections, a weekly pill for HIV treatment, injectable PrEP, vaginal PrEP rings, and PrEP implants.

By Larry Buhl
Researchers on a Zoom meeting during a CROI 2021 press conference

CROI 2021 Data Bites: HIV Prevention and Epidemiology

From new forms of PrEP to new data on HIV in the U.S., CROI 2021 has plenty of developments to report when it comes to preventing HIV and better understanding the drivers of the modern epidemic.

By Myles Helfand and Larry Buhl
CROI 2019

New COVID-19 Research and HIV Intervention Breakthroughs Are on the Menu at CROI 2021

Arriving on the one-year anniversary of nationwide COVID-19 shutdowns, the 2021 Conference on Retroviruses and Opportunistic Infections won't be in person this year—but it will emphasize COVID-19 alongside important HIV prevention and treatment updates.

By Larry Buhl
pregnant check-up

Some Research on Pregnant and Postpartum Women with HIV Is Presented at CROI, But More Trials Are Needed

Pregnant people who are living with or vulnerable to HIV need to be included in clinical trials in order to close our knowledge gaps.

By Barbara Jungwirth
vaccine trial

Researchers Discuss the Lessons of the HIV Vaccine Trial That Terminated Earlier This Year

HVTN 702 may not have proven an effective vaccine, but scientists still learned from the research.

By Barbara Jungwirth
pill bottles and cash

A PrEP Pricing Pickle: Descovy Will Need a Drastic Discount to Be Worthwhile, Study Finds

With Truvada going generic soon in the U.S., public health officials will need to make some decisions to make access to both drugs sustainable.

By Myles Helfand